Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Entertainment
  • Real Estate
  • Business
  • Technology
  • Artificial Intelligence
  • Non-profit
ncarol.com

Galaxy Diagnostics Launches Broadest IFA Serology Panel Available for Bartonella Infection
ncarol.com/10129159

Trending...
  • UK Financial Ltd Launches MayaSwap On MAYA CHAIN To Facilitate UKFLMS-For-Gold Swaps, Officially Transforming UKFLMS From Meme Into A Real-World Asset
  • Record Q3 Revenue and Gross Profit Delivered: Revenue Surges 40%, Gross Margin Soars to 36% & Adjusted EBITDA Loss Narrows 64% for Cycurion, Inc $CYCU
  • LGF Lab Gas Flow Launches Fully Automatic Laboratory Gas Changeover Manifold System with Ultra High Purity Gas Regulator Valve
Ifa Pr Post Only Bartonella test that detects 4 species Identifies Bartonella cases missed by other tests Galaxy Diagnostics Go Beyond the Limits Buttershop Digital Agency
Science Leader in the Testing of Flea and Tick-Borne Illness Introduces 4 Species IgG Antibody Test Panel for Bartonella Infection

DURHAM, N.C. - ncarol.com -- Galaxy Diagnostics, Inc., the science leader in sample enrichment powered testing solutions for elusive flea and tick-borne pathogens, today announced the launch of the most comprehensive Bartonella IFA Serology (IgG) Panel commercially available for human health testing.

This expanded antibody test panel provides evidence of exposure to four zoonotic Bartonella species: Bartonella henselae, Bartonella quintana, Bartonella koehlerae, and Bartonella vinsonii berkhoffii. With over 30 identified species and more than 10 species implicated in human disease, Bartonella species infection is one of the more important emerging infectious diseases on the clinical radar today.

Bartonella species are known to cause a range of diseases in people, including cat scratch disease, trench fever, culture negative endocarditis, rheumatologic disease, neurobartonellosis, vasoproliferative tumors, optic neuritis and other diseases. The new four species panel provides important advantages over standard antibody testing, namely:
  • Identifies positive cases missed by conventional antibody testing
  • Detects IgG antibodies against 4 most common Bartonella species implicated in human disease
  • Advances Bartonella testing for high-risk populations, such as veterinary workers
Indirect immunofluorescence assay (IFA) testing for bartonellosis determines the presence or absence of antibodies to a single Bartonella species within patient serum samples. Clinically, measured antibody levels (titers) are considered to be indicative of an individual's prior exposure or current immune response against a specific pathogen. The presence of antibodies indicates that a patient has been exposed to a particular species of Bartonella. High titers against a Bartonella species are indicative of active infection, according to established medical guidelines for cat scratch disease and Bartonella endocarditis.

More on ncarol.com
  • NANNNA Shines in Stamford: The Men Who Came to Support Their Wives
  • Aoolia Offers Free Virtual Try On Glasses for 1,500+ Frames Using Just a Phone Camera
  • Education Through Music-LA Honors Grammy-Winning Pitch Perfect Music Supervisors Julianne Jordan & Julia Michels, Educator Anthony "Tony" White
  • TOKSTAR Welcomes NBA 2K Star Young Wayne
  • Matt Zavala of Zavala Law, PC Elected to Ventura County Bar Association Board of Directors

"Advancing the sensitivity of existing test offerings is central to our mission to bring the most scientifically advanced diagnostic test options to the forefront of flea and tick-borne disease", said Galaxy CEO Amanda Elam. "Bartonella species infection represents an important and fast-growing area of emerging infectious disease. A growing body of published research suggests these pathogens play a key role in chronic illness, from cancer etiology to heart and liver infection, especially for those individuals with high exposure to fleas, ticks, lice, and animals. We are committed to improving the broadest, most sensitive and specific test options for these elusive, low abundance pathogens. The path to better patient care in this area of emerging infectious disease starts with more reliable and accurate testing developed by global experts in flea and tick-borne disease."

Galaxy advocates for a new standard of care in Bartonellosis testing and recommends a combination diagnostic protocol with Bartonella Digital ePCR™ to confirm active infection and the newly expanded Bartonella IFA Serology Panel to detect the presence of IgG antibodies.

You can order here and learn more at galaxydx.com.

More on ncarol.com
  • Bryan Regan Photography shoots for GQ Magazine
  • Montana Artist Ryan Jolley Receives Goodman Award at Mountain Oyster Club Art Show
  • Make Your Move to Luxury Living at Heritage at Hopewell with Rates Starting at Just 3.750% (5.803% APR)
  • Scott Glickson Joins STS Capital Partners as Managing Director
  • BREAKTHROUGH TROP2 Research Reveals New REQORSA® Opportunities as Roche Collaboration Strengthens Precision Lung Cancer Strategy

About Galaxy Diagnostics


Galaxy Diagnostics is a privately held medical laboratory located in Research Triangle Park offering the only testing solutions powered by revolutionary sample enrichment technologies for elusive flea and tick borne pathogens. The company's mission is to "Go Beyond" the limits of conventional detection by driving scientific innovation, creating new clinical knowledge through research and publication, and providing medical education and excellent customer support to healthcare providers, veterinarians, patients, and research customers in this important area of emerging infectious disease.

Contact
James Rebenski
***@galaxydx.com


Source: Galaxy Diagnostics, Inc.
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Inaugural 12 Trees of Christmas gala raises $525,000 for DMG research and family support
  • BitTitan Expands MigrationWiz with SharePoint Sites Migration and Simplified Collaboration Licensing
  • Olympic champion Katie Moon to compete at Pole Vault in Paradise in Key West
  • The Seaside Art Gallery Presents
  • Smith Strong Merges With Gravis Law, Bringing Gravis Law to Virginia
  • Asheville-Based KayeDinero Surpasses 100-Track Goal as Detroit Lions Win 35-10 in Munich
  • Turkish Engineer Who Cracked Wall Street's Algorithm Launches Hermes AI Analyzer
  • Nious Media Expands Gaming Coverage With 2026 Game & Geek Expo Special
  • UK Financial Ltd Launches MayaSwap On MAYA CHAIN To Facilitate UKFLMS-For-Gold Swaps, Officially Transforming UKFLMS From Meme Into A Real-World Asset
  • The Dark Chocolate Nutcracker Marks 15 Years
  • Entrepreneur Nouho M Kanneh Talks Family, Faith and a $37 Million Portfolio in New Interview
  • Emerald Williams Selected to Super Lawyers Rising Stars 2022-2026
  • Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
  • Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
  • Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
  • The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
  • After Nvidia's 14% Drop, Asheville Artist KayeDinero Releases "Nvidia"
  • LCH2 Awarded Additional $1 Million to Advance Lewis County Clean Energy Campus
  • Security Planning Tips For Your Holiday Event From Access Patrol Services
  • Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
_catLbl0 _catLbl1

Popular on ncarol.com

  • Nious Media Expands Independent Entertainment Network Through Gaming, Music and Digital Storytelling - 232
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform - 229
  • North Carolina Author Carrie Sybert Celebrates Three Published Books - 204
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 142
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 132
  • Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration - 127
  • Unlocking the Next Phase of Growth with New AI Innovations; Targeting 2027 as Breakeven; Revenue Momentum Accelerates: ZenaTech (N A S D A Q: ZENA) - 122
  • Alan Hamilton of Shiver Hamilton Campbell Inducted as a Fellow of the American College of Trial Lawyers - 122
  • New Finnish Affiliate Site Ilmaiskierrokset.com Puts Wager-Free Spins in the Spotlight - 112
  • Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position - 111

Similar on ncarol.com

  • They Split the Brick. OG Mack Drama Kept the Foundation
  • NANNNA Shines in Stamford: The Men Who Came to Support Their Wives
  • Scott Glickson Joins STS Capital Partners as Managing Director
  • BREAKTHROUGH TROP2 Research Reveals New REQORSA® Opportunities as Roche Collaboration Strengthens Precision Lung Cancer Strategy
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Dallas–Fort Worth
  • Loud! OOH Launches UK's First Free Planning Tool for UK Outdoor Advertising Budgets
  • Boston Industrial Solutions Introduces the New Volta® M100 Pad Printing Machine
  • Not a Black Box Launches TalentOS, the First Talent Harness Operating System
  • What If the Greatest Gift This Holiday Season Came in a Dream of Your Loved One in Spirit?
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Minneapolis
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute